Posts by Sandra Ansanay-Alex
Bloom Biorenewables Raises CHF 13 Million
Fribourg-based startup Bloom Biorenewables SA, a pioneer in the conversion of biomass into sustainable alternatives to petroleum-based products, has successfully closed a CHF 13 million funding round. This milestone will enable the company to accelerate its growth and take a major step toward building its first industrial-scale facility by 2027. Led by Anaïs Ventures and…
Read MoreThe CHUV inaugurates the new Children’s Hospital
The new Children’s Hospital opens on 14 May 2025 at the end of a complex construction project that began in 2019 in the heart of Lausanne’s hospital district. The building will bring together the majority of the CHUV’s paediatric activities, currently spread over two sites, in a place designed specifically to meet the needs of…
Read MoreArtiria Medical and Reverso Therapeutics Awarded at BIND – BioInnovation Day
250 key players of the Swiss Health Valley gathered at Campus Biotech Geneva on 1 April 2025 for the 10th edition of BIND-BioInnovation Day. 29 groundbreaking life sciences projects developed in Western Switzerland Academic Institutions pitched in front of the audience. Artiria Medical and Reverso Therapeutics won the Best Startup Award and the Best Academic…
Read MoreSICTIC Investors Day – FONGIT
The 144th SICTIC Investor Day is taking place on 30 September 2025 at FONGIT in Plan-les-Ouates Geneva. Deadline for project submission is 4 September 2025. On September 30, 2025, join SICTIC at FONGIT in Geneva for the 144th SICTIC Investor Day, where groundbreaking startups meet forward-thinking investors. This event, hosted at Geneva’s premier…
Read MoreArkaiya receive support from FIT
The Fondation for Innovation Technologique is announcing support for three new start-ups, among them, a Tech Seed loans worth CHF 100,000 to Arkaiya for its innovative nutrition system. Over the last ten years, research into the microbiome has exploded because of its links with numerous diseases. The development of the microbiome, which takes place…
Read MoreClee Medical Receives CHF 150,000 Venture Kick
To meet the challenges of precision and efficiency in neurosurgery, Wyss Center spin-off Clee Medical is developing a technology designed to improve neurosurgical interventions through advanced imaging and artificial intelligence-assisted guidance. The start-up has received CHF 150,000 from Venture Kick, winning the third stage of the programme. Current neurosurgical procedures face significant obstacles…
Read MoreCarewell Secures CHF 150,000 from Venture Kick to Transform Healthcare Staffing Solutions
As Switzerland faces a growing shortage of healthcare professionals, Carewell is stepping up to bridge the gap by connecting institutions with professionals seeking flexible work opportunities. To accelerate its platform’s development, Venture Kick has awarded Carewell CHF 150,000 in funding. The Swiss healthcare sector is currently experiencing a critical workforce shortage, with approximately 11,000…
Read MorePeriVision, Bioscibex and Carewell receive support from FIT
Perivision and its software combining artificial intelligence and complex algorithms to carry out vision examinations, Bioscibex and its innovative bioreactor for drug production, and Carewell and its platform connecting the needs of health and care facilities with available qualified personnel. All three received support from FIT via a Tech Growth loan of CHF 300,000, a…
Read MoreSwiss Medtech Award 2025
evismo, QUMEA, and Bonebridge have reached the finals for the renowned Swiss Medtech Award 2025. The three companies will compete for a chance to win this prestigious honour recognising innovation and entrepreneurial excellence in the Swiss medtech sector. The winner of CHF 50,000 and the coveted trophy will be announced on 25 June during Swiss…
Read MoreBeech Biotech Secures €500,000 Grant
Lausanne-based startup Beech Biotech has been awarded €500,000 through the BioInnovation Institute (BII) Venture Lab programme to accelerate the development of a novel placenta-impermeable antibody aimed at treating preeclampsia, a life-threatening pregnancy complication. Addressing a Critical Unmet Medical Need Preeclampsia remains a major global health challenge, affecting millions of pregnancies each year. The condition,…
Read More